A detailed history of Ameriprise Financial Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Ameriprise Financial Inc holds 14,273,998 shares of JNJ stock, worth $2.19 Billion. This represents 0.61% of its overall portfolio holdings.

Number of Shares
14,273,998
Previous 14,374,397 0.7%
Holding current value
$2.19 Billion
Previous $2.1 Billion 10.1%
% of portfolio
0.61%
Previous 0.58%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $14.6 Million - $16.8 Million
-100,399 Reduced 0.7%
14,273,998 $2.31 Billion
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $109 Million - $119 Million
754,200 Added 5.54%
14,374,397 $2.1 Billion
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $170 Million - $178 Million
1,095,354 Added 8.75%
13,620,197 $2.15 Billion
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $138 Million - $151 Million
950,458 Added 8.21%
12,524,843 $1.96 Billion
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $408 Million - $458 Million
-2,622,669 Reduced 18.47%
11,574,385 $1.8 Billion
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $112 Million - $121 Million
-728,140 Reduced 4.88%
14,197,054 $2.35 Billion
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $384 Million - $459 Million
-2,544,534 Reduced 14.57%
14,925,194 $2.31 Billion
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $275 Million - $308 Million
-1,714,223 Reduced 8.94%
17,469,728 $3.09 Billion
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $58.7 Million - $65.3 Million
-363,736 Reduced 1.86%
19,183,951 $3.14 Billion
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $245 Million - $270 Million
-1,453,782 Reduced 6.92%
19,547,687 $3.47 Billion
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $20.1 Million - $22.8 Million
-126,960 Reduced 0.6%
21,001,469 $3.71 Billion
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $191 Million - $211 Million
1,221,877 Added 6.14%
21,128,429 $3.6 Billion
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $92.2 Million - $102 Million
570,900 Added 2.95%
19,906,552 $3.21 Billion
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $166 Million - $178 Million
1,040,348 Added 5.69%
19,335,652 $3.19 Billion
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $256 Million - $285 Million
-1,673,694 Reduced 8.38%
18,295,304 $3.01 Billion
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $85.2 Million - $97.8 Million
621,147 Added 3.21%
19,968,998 $3.14 Billion
Q3 2020

Nov 16, 2020

BUY
$140.38 - $153.83 $32.3 Million - $35.3 Million
229,773 Added 1.2%
19,347,851 $2.88 Billion
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $221 Million - $266 Million
1,712,137 Added 9.84%
19,118,078 $2.69 Billion
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $316 Million - $438 Million
2,841,388 Added 19.51%
17,405,941 $2.28 Billion
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $109 Million - $125 Million
-853,024 Reduced 5.53%
14,564,553 $2.12 Billion
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $596,665 - $668,057
-4,700 Reduced 0.03%
15,417,577 $1.99 Billion
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $225 Million - $247 Million
-1,713,068 Reduced 10.0%
15,422,277 $2.15 Billion
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $164 Million - $182 Million
-1,303,384 Reduced 7.07%
17,135,345 $2.4 Billion
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $37.5 Million - $45.1 Million
304,939 Added 1.68%
18,438,729 $2.38 Billion
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $176 Million - $207 Million
1,445,417 Added 8.66%
18,133,790 $3.25 Billion
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $150 Million - $166 Million
-1,258,871 Reduced 7.01%
16,688,373 $2.02 Billion
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $173 Million - $205 Million
1,382,004 Added 8.34%
17,947,244 $2.3 Billion
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $123 Million - $134 Million
-935,041 Reduced 5.34%
16,565,240 $2.31 Billion
Q3 2017

Nov 07, 2017

BUY
$129.47 - $135.38 $2.27 Billion - $2.37 Billion
17,500,281
17,500,281 $2.27 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $400B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.